$$$$$$$$$$$$$$
NSAV 8-K officially Eli LillY contract VSRI 12/21/2017
Shanghai based Vital Strategic Research Institute (VSRI), has signed an agreement with Eli Lilly and Company. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China
*******Copie of Contract*************
http://nsavholdinginc.com/files/VSRI-Eli-Lilly.pdf
Ceo James Tilton wants to be clear with everything
Officieel op Sec EDGAR Search Results
https://www.sec.gov/cgi-bin/browse-edgar?company=Net+Savings+Link%2C+Inc.&owner=exclude&action=getcompany
OTC Reporting
https://www.otcmarkets.com/stock/NSAV/news
ELI LILLY AND COMPANY AND SUBSIDIARIES 2016
Financial Highlights>>>> Revenu 2016 $ 21Billion !!! Netto income 2.7Billion
https://en.wikipedia.org/wiki/Eli_Lilly_and_Company
Eli Lilly builds $23B-plus Sales Forecast for 2017 on diabetes, cancer launches
https://www.fiercepharma.com/pharma/facing-cialis-patent-expiration-and-pricing-strife-diabetes-eli-lilly-eyes-new-launches-for
**China spends $50 billion treating diabetes and related diseases every year,
https://blogs.wsj.com/chinarealtime/2016/11/14/chinas-diabetes-problem-from-1-to-10-in-36-years/
**China, about 230 million people have cardiovascular disease.1
http://www.wpro.who.int/china/mediacentre/factsheets/cvd/en/
ELI LILLY AND CO Share price $ 87.00 Not a bad company to work with!!!
https://www.marketwatch.com/investing/stock/lly
Never buy or sell based on anything I post - MY POSTS ARE ALWAYS JUST MY OPINION, regardless whether I include that in my post or not. I am not a financial advisor and anything I post should be considered only my opinion at that time.
Recent LLY News
- Lilly Declares Second-Quarter 2024 Dividend • PR Newswire (US) • 05/06/2024 03:32:00 PM
- Futures Pointing To Roughly Flat Open On Wall Street • IH Market News • 04/30/2024 01:07:52 PM
- U.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate Decision • IH Market News • 04/30/2024 11:59:59 AM
- HSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in Earnings • IH Market News • 04/30/2024 11:55:21 AM
- Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum • PR Newswire (US) • 04/30/2024 10:45:00 AM
- Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity • PR Newswire (US) • 04/17/2024 10:15:00 AM
- Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement • PR Newswire (US) • 04/16/2024 02:00:00 PM
- Cal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and More • IH Market News • 04/03/2024 11:12:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:27:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 08:24:43 PM
- More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study • PR Newswire (US) • 03/10/2024 08:00:00 PM
- U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab • PR Newswire (US) • 03/08/2024 11:45:00 AM
- Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care • PR Newswire (US) • 03/07/2024 01:00:00 PM
- Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting • PR Newswire (US) • 03/05/2024 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:26:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:24:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:21:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:18:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:16:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:05:40 PM
- Lilly to Participate in Cowen's 44th Annual Health Care Conference • PR Newswire (US) • 02/20/2024 03:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:05:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 08:05:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:44:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:43:17 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM